J. Roney

发表

Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial.

M. Hellard, J. Sasadeusz, M. Stoové, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study

J. Druce, T. Tran, M. Catton, 2022, The Lancet Regional Health - Western Pacific.

Experiences and expectations of participants completing an HIV cure focused clinical trial.

S. Lewin, J. Elliott, J. McMahon, 2015, AIDS.

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

A. Cheng, A. Peleg, J. Sasadeusz, 2020, Trials.

Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial

M. Kainer, A. Peleg, J. Trubiano, 2022, eClinicalMedicine.

Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy

D. Hazuda, S. Lewin, R. Sékaly, 2014, PLoS pathogens.

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.

Rebecca Hoh, Wendy Hartogensis, Peter Bacchetti, 2015, The lancet. HIV.

FRI-228-Community-based hepatitis C treatment of people who inject drugs and their injecting network is feasible and effective: Results from the TAP (Treatment And Prevention) study

M. Hellard, E. McBryde, A. Pedrana, 2019, Journal of Hepatology.

Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.

M. Hellard, A. Pedrana, M. Stoové, 2019, The International journal on drug policy.

The impact of point‐of‐care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study

M. Hellard, A. Pedrana, M. Stoové, 2022, Journal of viral hepatitis.

HealthMap: a cluster randomised trial of interactive health plans and self-management support to prevent coronary heart disease in people with HIV

R. Osborne, A. Tonkin, S. Lewin, 2016, BMC Infectious Diseases.

High-risk behaviour in a cohort of HIV/hepatitis C coinfected gay and bisexual men commencing hepatitis C treatment

Richard D Moore, M. Hellard, E. Gane, 2017 .

Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial

C. Stedman, M. Hellard, D. Petrie, 2018, Trials.

No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy

S. Lewin, D. Purcell, H. Prince, 2017, AIDS.

Outcomes of treatment for hepatitis C in primary care compared to hospital-based care: a randomised controlled trial in people who inject drugs.

C. Stedman, M. Hellard, D. Petrie, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Rapid-EC study – A feasibility study of point-of-care testing in community clinics targeted to people who inject drugs in Melbourne, Australia

M. Hellard, A. Pedrana, A. Thompson, 2018 .

Asymptomatic people with well-controlled HIV do not have abnormal left ventricular global longitudinal strain

A. Dart, E. Dewar, J. Hoy, 2023, Frontiers in cardiovascular medicine.

A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls

G. Egan, M. Nussenzweig, A. Scott, 2021, EBioMedicine.